MedTrace Logo

The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations

NCT05113420 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-11-09

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy and safety of different phlebotonic drugs in children and to assess patient satisfaction after treatment.

Conditions

  • Drug Effect
  • Children, Only
  • Vascular Malformations
  • Surgery

Interventions

DRUG

Detralex

Diosmin+ Hesperidin

DRUG

Troxevasin

Troxerutin

Sponsors & Collaborators

  • Center for Vascular Pathology, Moscow

    lead OTHER

Principal Investigators

  • Ekaterina Listovskaia, MD · Vascular Anomalies Center (VAC) "Hemangioma" LLC.

  • Dmitriy Romanov, MD · Vascular Anomalies Center (VAC) "Hemangioma" LLC.

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-17
Primary Completion
2021-11-17
Completion
2022-09-17
FDA Drug
Yes

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05113420 on ClinicalTrials.gov